TickerFacts.

Femasys Inc (FEMY): Gross Profit

Annual figures by period end, from SEC filings. For years the company left out, it is revenue minus cost of revenue, computed by TickerFacts; where both exist they agree (see each figure's source).

Computed by TickerFacts from revenue minus cost of revenue. This may differ from the issuer's reported gross profit or margin; check the revenue and cost definitions.

$1.42M
Year ended 2025-12-31
$1.40M
Trailing 12 months to 2026-06-30
+23.0%
3-year compound annual growth
+14.2%
5-year compound annual growth
2020-12-31: $731.4K2021-12-31: $809.3K2022-12-31: $764.3K2023-12-31: $691.9K2024-12-31: $1.08M2025-12-31: $1.42M$1.42M
2020-12-31 Gross Profit (USD) 2025-12-31
Period endedGross ProfitChange YoYSource filing
2025-12-31$1.42M+31.1%2026-03-31, From 2025-01-01
2024-12-31$1.08M+56.7%2026-03-31, From 2024-01-01
2023-12-31$691.9K-9.5%2025-03-27, From 2023-01-01
2022-12-31$764.3K-5.6%2023-07-24, From 2022-01-01
2021-12-31$809.3K+10.7%2023-07-24, From 2021-01-01
2020-12-31$731.4Kn/a2022-03-24, From 2020-01-01

Gross Profit at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedGross ProfitChange YoY
Femasys Inc (FEMY)2025-12-31$1.42M+31.1%
QHSLab, Inc. (USAQ)2025-12-31$1.81M+33.4%
Vycor Medical Inc (VYCO)2025-12-31$1.56M+9.7%
OSR Health, Inc. (OSRH)2025-12-31$592.9K-26.9%
EBR Systems, Inc. (NONE.)2025-12-31$490.0Kn/a
Nuo Therapeutics, Inc. (AURX)2025-12-31$2.22M+108.8%
IceCure Medical Ltd. (ICCM)2025-12-31$1.23M-15.5%
Tenon Medical, Inc. (TNON)2025-12-31$2.36M+37.8%
Intelligent Bio Solutions Inc. (INBS)2026-06-30$2.05M+64.4%

Compare FEMY, USAQ, VYCO, OSRH side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗